Search results for: 'vitro diagnostics'

Electric vehicle (EV) battery aftersales are a key aspect of the EV customer journey, as they affect the vehicle s performance, reliability, and lifespan. Original equipment manufacturers (OEMs) need to offer innovative and tailored solutions that address customer pain points and preferences, such as battery health monitoring, warranty extension, r...

The lighting industry is evolving beyond traditional illumination solutions toward intelligent automation and real-time monitoring that adapts to occupancy patterns and environmental conditions. The growing emphasis on intelligence, connectivity, sustainability, and innovative service-based models presents ample growth opportunities for businesses,...

Connected services in passenger vehicles are undergoing a strategic transformation in Europe, reshaping how automakers engage with customers, manage vehicle life cycles, and build digital revenue streams. This Frost & Sullivan analysis examines how leading European original equipment manufacturers (OEMs) are developing group-level software platform...

Microbiome research is on the rise following technological advancements and significant cost reductions in microbiome analysis. Research has unlocked the potential of microbiome in medical use cases, yielding tremendous insights on its nature, interactions, and impact within a host and in an external environment. Advanced studies on the role of mic...

In 2003, the first human genome sequence was produced, with a production cost between $500 million and $1 billion. However, since 2008, when next-generation sequencing (NGS) approaches entered the research setting, there has been a significant decline in sequencing costs. These approaches allow either the whole genome (via whole-genome sequencing [...

Pharmaceutical drug discovery and development suffers from declining success rates with new molecules, and the rate of return has shrunk from 16% in 2011 to almost 11% in 2018. Frost & Sullivan finds that traditional solutions focused primarily on data from limited sources and rule-based computational techniques used to address the understanding of...

25 Apr 2022  |  North America  |  Frost Radar

Frost Radar™: Artificial Intelligence-enabled Drug Discovery, 2022

A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

Infographics

×

Pharmaceutical drug discovery and development has been suffering from declining success rates with new molecules primarily because of poor external validity of preclinical models and lack of efficacy of the molecule in terms of the intended disease indication. Drug success rates continue to be in the range of only 1 in 10 that enters clinical phase...

The Transformational Health team at Frost & Sullivan provides critical insights into the US and EU laboratory information management system (LIMS) industry, highlighting the key growth opportunities, market revenue forecast, and trends that will play an important role in industry growth. The US and EU LIMS market covered in this study is segmented...

Sequencing technologies have evolved over the years to harness the value of the human genome and dive deep into DNA and RNA sequences which offer immense knowledge of human biology. From Sanger sequencing to next-generation sequencing, technologies and chemistries have improved/advanced to reduce costs and ensure faster timelines. NGS has integrate...